5JWM

Bivalent BET Bromodomain Inhibition

Summary for 5JWM

Entry DOI	10.2210/pdb5jwm/pdb
Descriptor	Bromodomain-containing protein 4, 2-[(9~{S})-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaen-9-yl]-~{N}-[2-[2-[2-[2-[2-[2-[2-[2-[2-[(9~{S})-7-(4-chlorophenyl)-4,5,13-trimethyl-3-thia-1,8,11,12-tetrazatricyclo[8.3.0.0^{2,6}]trideca-2(6),4,7,10,12-pentaen-9-yl]ethanoylamino]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethoxy]ethyl]ethanamide (3 entities in total)
Functional Keywords	bivalent-ligand, bromodomain, inhibitor, transcription-transcription inhibitor complex, transcription/transcription inhibitor
Biological source	Homo sapiens (Human)
Cellular location	Nucleus: O60885
Total number of polymer chains	2
Total formula weight	31254.86
Authors	Seo, H.-S.,Dhe-Paganon, S. (deposition date: 2016-05-12, release date: 2016-07-06, Last modification date: 2023-09-27)
Primary citation	Tanaka, M.,Roberts, J.M.,Seo, H.S.,Souza, A.,Paulk, J.,Scott, T.G.,DeAngelo, S.L.,Dhe-Paganon, S.,Bradner, J.E. Design and characterization of bivalent BET inhibitors. Nat.Chem.Biol., 12:1089-1096, 2016 Cited by PubMed: 27775715 DOI: 10.1038/nchembio.2209 PDB entries with the same primary citation
Experimental method	X-RAY DIFFRACTION (1.71 Å)

Structure validation